Expleo Solutions Limited – Investor Presentation Summary
Key Operational Highlights
- Operating Revenue was ₹2,916 million in Q1 FY27, showing sequential growth of 1.8% from Q4 FY26 (₹2,863 million) and year-over-year growth of 12.3% from Q1 FY26 (₹2,596 million).
- Total Income was ₹2,985 million in Q1 FY27, showing flat sequential performance compared to Q4 FY26 (₹2,989 million) but year-over-year growth of 12.0% from Q1 FY26 (₹2,666 million).
- Employee costs were ₹1,835 million in Q1 FY27, showing a slight sequential decrease of 0.1% from Q4 FY26 (₹1,837 million) and year-over-year increase of 11.3% from Q1 FY26 (₹1,650 million).
- Other expenditure increased to ₹657 million in Q1 FY27, up 9.8% sequentially from Q4 FY26 (₹598 million) and 2.7% year-over-year from Q1 FY26 (₹640 million).
Key drivers of operational performance: The year-over-year revenue growth was driven by increased business activity, though sequential growth was modest. Other expenditure saw significant sequential increase impacting margins.
Segment-wise Performance
- Not Specified
Explanation of significant changes in segment performance: Not Specified
Financial Highlights
Revenue: ₹2,916 million (Operating Revenue)
EBITDA: ₹424 million (Adjusted EBITDA)
PAT: ₹354 million (Total Comprehensive Income)
EPS: ₹22.02 (Basic EPS)
Margins: Adjusted EBITDA margin of 14.5%, PAT margin of 11.8%
YoY/QoQ comparison: Year-over-year, PAT grew 43.0% from ₹247 million in Q1 FY26. Quarter-over-quarter, PAT declined 28.3% from ₹493 million in Q4 FY26. Adjusted EBITDA grew 27.6% YoY but declined 4.8% QoQ.
Drivers of financial performance: The year-over-year improvement was driven by revenue growth and operational efficiency. The sequential decline was primarily due to increased other expenditure and lower other income.
Comparison to market estimates: Not Specified
Key Risks: Not explicitly disclosed in the presentation.
Geographical Revenue Split
Domestic vs Export/Regional Revenue: Not Specified
Regional Breakdown: Not Specified
Balance Sheet Snapshot
Net Debt/Equity: Net cash position of ₹3,528 million vs ₹3,757 million in Q4 FY26 and ₹2,382 million in Q1 FY26.
Reserves: Not Specified
Current Assets/Liabilities: Not Specified
Working Capital/Leverage Metrics: Not Specified
Financial Health Insights: The company maintains a strong net cash position despite sequential decrease, indicating healthy liquidity.
Capex & Cash Flow Health
Capital Expenditure: Not Specified
Free Cash Flow: Not Specified
Operating Cash Flow: Not Specified
Net Debt Movement: Net cash decreased sequentially from ₹3,757 million in Q4 FY26 to ₹3,528 million in Q1 FY27.
Investment Rationale: Not Specified
Strategic & R&D Initiatives
Investments in Innovation: Not Specified
Expected impact on growth: Not Specified
Strategic Rationale: Not Specified
Industry Trends & Business Environment
Macro/Industry Trends: Not Specified
Impact on Company: Not Specified
Management Commentary & Growth Outlook
Strategic Outlook: Not Specified
FY Guidance: Not Specified
Market Share Targets: Not Specified
Risks and Opportunities: Not Specified